Inventor
SEYMOUR JOHN F
AU3 patents
Patents
3 patentsUS11590128B2Feb 28, 2023
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
GENENTECH INC3 citations80
US11110087B2Sep 7, 2021
Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor
GENENTECH INC5 citations80
US10993942B2May 4, 2021
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
GENENTECH INC3 citations80